1. People

Emily K. Hill, MD

Clinical Associate Professor of Obstetrics and Gynecology-Gynecologic Oncology

Current Positions

  • Clinical Associate Professor of Obstetrics and Gynecology - Gynecologic Oncology

Education

  • BA in Russian Studies, Brown University, Providence, Rhode Island
  • MD in Medical School, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
  • Resident in Obstetrics and Gynecology, University of Chicago Hospitals
  • Fellow in Gynecologic Oncology and Breast Surgery, Brown University/Women & Infants Hospital

Licenses & Certifications

  • American Board of Obstetrics and Gynecology, Board Certification in Gynecologic Oncology
  • Medical License (Iowa), MD-42703
  • American Board of Obstetrics and Gynecology, Board Certification in General Obstetrics and Gynecology

Selected Publications

  • Eskander RN, Sill MW, Beffa L, Moore RG, Hope JM, Musa FB, Mannel RS, Shahin MS, Cantuaria GH, Girda E, Lokich E, Kavecansky J, Leath CA 3rd, Gien LT, Hinchcliff EM, Lele SB, Landrum LM, Backes F, O'Cearbhaill RE, Baghdadi TA, Hill EK, Thaker PH, John VS, Welch S, Fader AN, Powell MA, Aghajanian C. Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial. Nat Med. 2025 Mar 5. doi: 10.1038/s41591-025-03566-1. Epub ahead of print. PMID: 40044930. https://www.nature.com/articles/s41591-025-03566-1
  • Rocque GB, Dent DN, Waugh C, Hill EK, Federman N, Bostock Rosenzweig I, Morris B, Kamal A. Evaluating the implementation and impact of a volunteer navigation oncology support programme: study protocol for a pragmatic, real-world hybrid type 2 study. BMJ Open. 2025 Jan 20;15(1):e088047. doi: 10.1136/bmjopen-2024-088047. PMID: 39832972. https://bmjopen.bmj.com/content/bmjopen/15/1/e088047.full.pdf
  • Gorzelitz J, Adeagbo M, Dungan-Seaver S, Hill EK, Kumar A, Goodheart MJ, Lutgendorf S. Attitudes, beliefs and preferences surrounding home-based exercise programs in endometrial cancer patients receiving treatment. Gynecol Oncol Rep. 2024 Dec 18;57:101659. doi: 10.1016/j.gore.2024.101659. PMID: 39811828; PMCID: PMC11730264. https://pmc.ncbi.nlm.nih.gov/articles/PMC11730264/pdf/main.pdf
  • Gabrielle Rocque, MD, MSPH; D’Ambra Dent, MBA ; Charlotte Waugh; Emily Hill, MD; Noah Federman, MD; Ian Bostock Rosenzweig, MD; Arif Kamal, MD, MBA; Bonny Morris, PhD, MSPH, RN . Evaluating the implementation and impact of a volunteer navigation oncology support program: study protocol for a pragmatic, real-world hybrid type 2 study. BMJ Open
  • Ramez Eskander, Michael Sill, Lindsey Beffa, Richard Moore, Joanie Hope, Fernanda Musa, Robert Mannel, Mark Shahin, Guilherme Cantuaria, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles Leath, Lilian Gien, Emily Hinchcliff, Shashikant Lele, Lisa Landrum, Floor Backes, Roisin O'Cearbhaill, Rebecca Liu, Emily Hill, Premal H. Thaker, Veena John, Matthew Powell, Carol Aghajanian. Overall survival and progression-free survival by PD-L1 status among endometrial cancer patients treated with pembrolizumab plus carboplatin/paclitaxel as compared to carboplatin/paclitaxel plus placebo in the NRG GY018 trial.
  • Ramez Eskander, Michael Sill, Lindsey Beffa, Richard Moore, Joanie Hope, Fernanda Musa, Robert Mannel, Mark Shahin, Guilherme Cantuaria, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles Leath, Lilian Gien, Emily Hinchcliff, Shashikant Lele, Lisa Landrum, Floor Backes, Roisin O'Cearbhaill, Rebecca Liu, Emily Hill, Premal H. Thaker, Veena John, Matthew Powell, Carol Aghajanian. Overall survival and progression-free survival by PD-L1 status among endometrial cancer patients treated with pembrolizumab plus carboplatin/paclitaxel as compared to carboplatin/paclitaxel plus placebo in the NRG GY018 trial. Gynecologic Oncology, Volume 190, Supplement 1, 2024, Page S5, ISSN 0090-8258. https://doi.org/10.1016/j.ygyno.2024.07.015
  • Gorzelitz J, Adeagbo M, Dungan-Seaver S, Hill EK, Kumar A, Goodheart MJ, Lutgendorf S. Attitudes, beliefs and preferences surrounding home-based exercise programs in endometrial cancer patients receiving treatment. Gynecol Oncol Rep. 2024 Dec 18;57:101659. doi: 10.1016/j.gore.2024.101659. PMID: 39811828; PMCID: PMC11730264.
  • Metzger S, Ulmer K, Hill EK. Pembrolizumab-induced cytokine release syndrome with severe encephalopathy in the setting of clear cell vaginal carcinoma: A case report. Gynecol Oncol Rep. 2024 Oct 11;56:101529. doi: 10.1016/j.gore.2024.101529. PMID: 39494393; PMCID: PMC11530849. https://pmc.ncbi.nlm.nih.gov/articles/PMC11530849/
  • Faidley KN, Botkin HE, Loeffler BT, Mott SL, Hansen SC, Hill EK, Erickson BA. Longitudinal Outcomes of Malignant Ureteral Obstruction Secondary to Ovarian Cancer: Predictors of Resolution and the Role of Surgical Management. Urology. 2024 Apr;186:101-106. doi: 10.1016/j.urology.2024.02.001. Epub 2024 Feb 11. PMID: 38350551.
  • Botkin HE, Faidley KN, Loeffler BT, Mott SL, Hill EK, Erickson BA. Longitudinal Outcomes from Conservative Management of Cervical Cancer Associated Ureteral Obstruction. Urology. 2021 Dec;158:208-214. doi: 10.1016/j.urology.2021.09.007. Epub 2021 Sep 25. PMID: 34582886.

People